| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |